EMEA (Europe, Middle East and Africa) Solid Tumor Drug Market Report 2017

August 2017 | 113 pages | ID: E497F1685BFEN
QYResearch

Abstracts

In this report, the EMEA Solid Tumor Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Solid Tumor Drug for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Solid Tumor Drug market competition by top manufacturers/players, with Solid Tumor Drug sales volume (MT), price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including

• AstraZeneca
• Biogen
• Baxter
• Celgene Corporation
• Abbott Laboratories
• Pfizer Inc
• Amgen Limited & Amgen Ireland Limited
• Bristol-Myers Squibb Company
• GlaxoSmithKline plc.
• F. Hoffmann-La Roche Ltd.
• Eli Lilly and Company
• Johnson & Johnson

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/Kg), market share and growth rate of each type, primarily split into

• Small Molecules
• Biologics

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (MT), market share and growth rate of Solid Tumor Drug for each application, including

• Oncology
• Neurology
• Radiology
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Solid Tumor Drug Market Report 2017

1 SOLID TUMOR DRUG OVERVIEW

1.1 Product Overview and Scope of Solid Tumor Drug
1.2 Classification of Solid Tumor Drug
  1.2.1 EMEA Solid Tumor Drug Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Solid Tumor Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Small Molecules
  1.2.4 Biologics
1.3 EMEA Solid Tumor Drug Market by Application/End Users
  1.3.1 EMEA Solid Tumor Drug Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Oncology
  1.3.3 Neurology
  1.3.4 Radiology
  1.3.5 Others
1.4 EMEA Solid Tumor Drug Market by Region
  1.4.1 EMEA Solid Tumor Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Solid Tumor Drug (2012-2022)
  1.5.1 EMEA Solid Tumor Drug Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Solid Tumor Drug Revenue and Growth Rate (2012-2022)

2 EMEA SOLID TUMOR DRUG COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Solid Tumor Drug Market Competition by Players/Manufacturers
  2.1.1 EMEA Solid Tumor Drug Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Solid Tumor Drug Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Solid Tumor Drug Sale Price by Players (2012-2017)
2.2 EMEA Solid Tumor Drug (Volume and Value) by Type/Product Category
  2.2.1 EMEA Solid Tumor Drug Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Solid Tumor Drug Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Solid Tumor Drug Sale Price by Type (2012-2017)
2.3 EMEA Solid Tumor Drug (Volume) by Application
2.4 EMEA Solid Tumor Drug (Volume and Value) by Region
  2.4.1 EMEA Solid Tumor Drug Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Solid Tumor Drug Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Solid Tumor Drug Sales Price by Region (2012-2017)

3 EUROPE SOLID TUMOR DRUG (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Solid Tumor Drug Sales and Value (2012-2017)
  3.1.1 Europe Solid Tumor Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Solid Tumor Drug Revenue and Growth Rate (2012-2017)
3.2 Europe Solid Tumor Drug Sales and Market Share by Type
3.3 Europe Solid Tumor Drug Sales and Market Share by Application
3.4 Europe Solid Tumor Drug Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Solid Tumor Drug Sales Volume by Countries (2012-2017)
  3.4.2 Europe Solid Tumor Drug Revenue by Countries (2012-2017)
  3.4.3 Germany Solid Tumor Drug Sales and Growth Rate (2012-2017)
  3.4.4 France Solid Tumor Drug Sales and Growth Rate (2012-2017)
  3.4.5 UK Solid Tumor Drug Sales and Growth Rate (2012-2017)
  3.4.6 Russia Solid Tumor Drug Sales and Growth Rate (2012-2017)
  3.4.7 Italy Solid Tumor Drug Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Solid Tumor Drug Sales and Growth Rate (2012-2017)

4 MIDDLE EAST SOLID TUMOR DRUG (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Solid Tumor Drug Sales and Value (2012-2017)
  4.1.1 Middle East Solid Tumor Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Solid Tumor Drug Revenue and Growth Rate (2012-2017)
4.2 Middle East Solid Tumor Drug Sales and Market Share by Type
4.3 Middle East Solid Tumor Drug Sales and Market Share by Application
4.4 Middle East Solid Tumor Drug Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Solid Tumor Drug Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Solid Tumor Drug Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Solid Tumor Drug Sales and Growth Rate (2012-2017)
  4.4.4 Israel Solid Tumor Drug Sales and Growth Rate (2012-2017)
  4.4.5 UAE Solid Tumor Drug Sales and Growth Rate (2012-2017)
  4.4.6 Iran Solid Tumor Drug Sales and Growth Rate (2012-2017)

5 AFRICA SOLID TUMOR DRUG (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Solid Tumor Drug Sales and Value (2012-2017)
  5.1.1 Africa Solid Tumor Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Solid Tumor Drug Revenue and Growth Rate (2012-2017)
5.2 Africa Solid Tumor Drug Sales and Market Share by Type
5.3 Africa Solid Tumor Drug Sales and Market Share by Application
5.4 Africa Solid Tumor Drug Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Solid Tumor Drug Sales Volume by Countries (2012-2017)
  5.4.2 Africa Solid Tumor Drug Revenue by Countries (2012-2017)
  5.4.3 South Africa Solid Tumor Drug Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Solid Tumor Drug Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Solid Tumor Drug Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Solid Tumor Drug Sales and Growth Rate (2012-2017)

6 EMEA SOLID TUMOR DRUG MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 AstraZeneca
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Solid Tumor Drug Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AstraZeneca Solid Tumor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Biogen
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Solid Tumor Drug Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Biogen Solid Tumor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Baxter
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Solid Tumor Drug Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Baxter Solid Tumor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Celgene Corporation
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Solid Tumor Drug Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Celgene Corporation Solid Tumor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Abbott Laboratories
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Solid Tumor Drug Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Abbott Laboratories Solid Tumor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Pfizer Inc
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Solid Tumor Drug Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Pfizer Inc Solid Tumor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Amgen Limited & Amgen Ireland Limited
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Solid Tumor Drug Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bristol-Myers Squibb Company
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Solid Tumor Drug Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bristol-Myers Squibb Company Solid Tumor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 GlaxoSmithKline plc.
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Solid Tumor Drug Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 GlaxoSmithKline plc. Solid Tumor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 F. Hoffmann-La Roche Ltd.
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Solid Tumor Drug Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Eli Lilly and Company
6.12 Johnson & Johnson

7 SOLID TUMOR DRUG MANUFACTURING COST ANALYSIS

7.1 Solid Tumor Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Solid Tumor Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Solid Tumor Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Solid Tumor Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA SOLID TUMOR DRUG MARKET FORECAST (2017-2022)

11.1 EMEA Solid Tumor Drug Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Solid Tumor Drug Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Solid Tumor Drug Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Solid Tumor Drug Price and Trend Forecast (2017-2022)
11.2 EMEA Solid Tumor Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Solid Tumor Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Solid Tumor Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Solid Tumor Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Solid Tumor Drug Sales Forecast by Type (2017-2022)
11.7 EMEA Solid Tumor Drug Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Solid Tumor Drug
Figure EMEA Solid Tumor Drug Sales Volume (MT) by Type (2012-2022)
Figure EMEA Solid Tumor Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Small Molecules Product Picture
Figure Biologics Product Picture
Figure EMEA Solid Tumor Drug Sales Volume (MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Solid Tumor Drug by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Neurology Examples
Table Key Downstream Customer in Neurology
Figure Radiology Examples
Table Key Downstream Customer in Radiology
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Solid Tumor Drug Market Size (Million USD) by Region (2012-2022)
Figure Europe Solid Tumor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Solid Tumor Drug Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Solid Tumor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Solid Tumor Drug Revenue (Million USD) Status and Forecast by Countries
Figure Africa Solid Tumor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Solid Tumor Drug Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Solid Tumor Drug Sales Volume and Growth Rate (2012-2022)
Figure EMEA Solid Tumor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Solid Tumor Drug Market Major Players Product Sales Volume (MT) (2012-2017)
Table EMEA Solid Tumor Drug Sales Volume (MT) of Major Players (2012-2017)
Table EMEA Solid Tumor Drug Sales Share by Players (2012-2017)
Figure 2016 Solid Tumor Drug Sales Share by Players
Figure 2017 Solid Tumor Drug Sales Share by Players
Figure EMEA Solid Tumor Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Solid Tumor Drug Revenue (Million USD) by Players (2012-2017)
Table EMEA Solid Tumor Drug Revenue Share by Players (2012-2017)
Table 2016 EMEA Solid Tumor Drug Revenue Share by Players
Table 2017 EMEA Solid Tumor Drug Revenue Share by Players
Table EMEA Solid Tumor Drug Sale Price (USD/Kg) by Players (2012-2017)
Table EMEA Solid Tumor Drug Sales (MT) and Market Share by Type (2012-2017)
Table EMEA Solid Tumor Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Solid Tumor Drug by Type (2012-2017)
Figure EMEA Solid Tumor Drug Sales Market Share by Type (2012-2017)
Table EMEA Solid Tumor Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Solid Tumor Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Solid Tumor Drug by Type in 2016
Table EMEA Solid Tumor Drug Sale Price (USD/Kg) by Type (2012-2017)
Table EMEA Solid Tumor Drug Sales (MT) and Market Share by Application (2012-2017)
Table EMEA Solid Tumor Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Solid Tumor Drug by Application (2012-2017)
Figure EMEA Solid Tumor Drug Sales Market Share by Application in 2016
Table EMEA Solid Tumor Drug Sales (MT) and Market Share by Region (2012-2017)
Table EMEA Solid Tumor Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Solid Tumor Drug by Region (2012-2017)
Figure EMEA Solid Tumor Drug Sales Market Share in 2016
Table EMEA Solid Tumor Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Solid Tumor Drug Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Solid Tumor Drug by Region (2012-2017)
Figure EMEA Solid Tumor Drug Revenue Market Share Regions in 2016
Table EMEA Solid Tumor Drug Sales Price (USD/Kg) by Region (2012-2017)
Figure Europe Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure Europe Solid Tumor Drug Revenue and Growth Rate (2012-2017)
Table Europe Solid Tumor Drug Sales (MT) by Type (2012-2017)
Table Europe Solid Tumor Drug Market Share by Type (2012-2017)
Figure Europe Solid Tumor Drug Market Share by Type in 2016
Table Europe Solid Tumor Drug Sales (MT) by Application (2012-2017)
Table Europe Solid Tumor Drug Market Share by Application (2012-2017)
Figure Europe Solid Tumor Drug Market Share by Application in 2016
Table Europe Solid Tumor Drug Sales (MT) by Countries (2012-2017)
Table Europe Solid Tumor Drug Sales Market Share by Countries (2012-2017)
Figure Europe Solid Tumor Drug Sales Market Share by Countries (2012-2017)
Figure Europe Solid Tumor Drug Sales Market Share by Countries in 2016
Table Europe Solid Tumor Drug Revenue (Million USD) by Countries (2012-2017)
Table Europe Solid Tumor Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Solid Tumor Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Solid Tumor Drug Revenue Market Share by Countries in 2016
Figure Germany Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure France Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure UK Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure Russia Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure Italy Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure Benelux Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Solid Tumor Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Solid Tumor Drug Sales (MT) by Type (2012-2017)
Table Middle East Solid Tumor Drug Market Share by Type (2012-2017)
Figure Middle East Solid Tumor Drug Market Share by Type (2012-2017)
Table Middle East Solid Tumor Drug Sales (MT) by Applications (2012-2017)
Table Middle East Solid Tumor Drug Market Share by Applications (2012-2017)
Figure Middle East Solid Tumor Drug Sales Market Share by Application in 2016
Table Middle East Solid Tumor Drug Sales Volume (MT) by Countries (2012-2017)
Table Middle East Solid Tumor Drug Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Solid Tumor Drug Sales Volume Market Share by Countries in 2016
Table Middle East Solid Tumor Drug Revenue (Million USD) by Countries (2012-2017)
Table Middle East Solid Tumor Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Solid Tumor Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Solid Tumor Drug Revenue Market Share by Countries in 2016
Figure Saudi Arabia Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure Israel Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure UAE Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure Iran Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure Africa Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure Africa Solid Tumor Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Solid Tumor Drug Sales (MT) by Type (2012-2017)
Table Africa Solid Tumor Drug Sales Market Share by Type (2012-2017)
Figure Africa Solid Tumor Drug Sales Market Share by Type (2012-2017)
Figure Africa Solid Tumor Drug Sales Market Share by Type in 2016
Table Africa Solid Tumor Drug Sales (MT) by Application (2012-2017)
Table Africa Solid Tumor Drug Sales Market Share by Application (2012-2017)
Figure Africa Solid Tumor Drug Sales Market Share by Application (2012-2017)
Table Africa Solid Tumor Drug Sales Volume (MT) by Countries (2012-2017)
Table Africa Solid Tumor Drug Sales Market Share by Countries (2012-2017)
Figure Africa Solid Tumor Drug Sales Market Share by Countries (2012-2017)
Figure Africa Solid Tumor Drug Sales Market Share by Countries in 2016
Table Africa Solid Tumor Drug Revenue (Million USD) by Countries (2012-2017)
Table Africa Solid Tumor Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Solid Tumor Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Solid Tumor Drug Revenue Market Share by Countries in 2016
Figure South Africa Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure Nigeria Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure Egypt Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure Algeria Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Table AstraZeneca Solid Tumor Drug Basic Information List
Table AstraZeneca Solid Tumor Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure AstraZeneca Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure AstraZeneca Solid Tumor Drug Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Solid Tumor Drug Revenue Market Share in EMEA (2012-2017)
Table Biogen Solid Tumor Drug Basic Information List
Table Biogen Solid Tumor Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Biogen Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure Biogen Solid Tumor Drug Sales Market Share in EMEA (2012-2017)
Figure Biogen Solid Tumor Drug Revenue Market Share in EMEA (2012-2017)
Table Baxter Solid Tumor Drug Basic Information List
Table Baxter Solid Tumor Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Baxter Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure Baxter Solid Tumor Drug Sales Market Share in EMEA (2012-2017)
Figure Baxter Solid Tumor Drug Revenue Market Share in EMEA (2012-2017)
Table Celgene Corporation Solid Tumor Drug Basic Information List
Table Celgene Corporation Solid Tumor Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Celgene Corporation Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure Celgene Corporation Solid Tumor Drug Sales Market Share in EMEA (2012-2017)
Figure Celgene Corporation Solid Tumor Drug Revenue Market Share in EMEA (2012-2017)
Table Abbott Laboratories Solid Tumor Drug Basic Information List
Table Abbott Laboratories Solid Tumor Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Abbott Laboratories Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure Abbott Laboratories Solid Tumor Drug Sales Market Share in EMEA (2012-2017)
Figure Abbott Laboratories Solid Tumor Drug Revenue Market Share in EMEA (2012-2017)
Table Pfizer Inc Solid Tumor Drug Basic Information List
Table Pfizer Inc Solid Tumor Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer Inc Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure Pfizer Inc Solid Tumor Drug Sales Market Share in EMEA (2012-2017)
Figure Pfizer Inc Solid Tumor Drug Revenue Market Share in EMEA (2012-2017)
Table Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Basic Information List
Table Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales Market Share in EMEA (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Revenue Market Share in EMEA (2012-2017)
Table Bristol-Myers Squibb Company Solid Tumor Drug Basic Information List
Table Bristol-Myers Squibb Company Solid Tumor Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Solid Tumor Drug Sales Market Share in EMEA (2012-2017)
Figure Bristol-Myers Squibb Company Solid Tumor Drug Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline plc. Solid Tumor Drug Basic Information List
Table GlaxoSmithKline plc. Solid Tumor Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc. Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure GlaxoSmithKline plc. Solid Tumor Drug Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline plc. Solid Tumor Drug Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche Ltd. Solid Tumor Drug Basic Information List
Table F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales (MT) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Solid Tumor Drug Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly and Company Solid Tumor Drug Basic Information List
Table Johnson & Johnson Solid Tumor Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Solid Tumor Drug
Figure Manufacturing Process Analysis of Solid Tumor Drug
Figure Solid Tumor Drug Industrial Chain Analysis
Table Raw Materials Sources of Solid Tumor Drug Major Manufacturers in 2016
Table Major Buyers of Solid Tumor Drug
Table Distributors/Traders List
Figure EMEA Solid Tumor Drug Sales (MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Solid Tumor Drug Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Solid Tumor Drug Price (USD/Kg) and Trend Forecast (2017-2022)
Table EMEA Solid Tumor Drug Sales (MT) Forecast by Region (2017-2022)
Figure EMEA Solid Tumor Drug Sales Market Share Forecast by Region (2017-2022)
Table EMEA Solid Tumor Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Solid Tumor Drug Revenue Market Share Forecast by Region (2017-2022)
Table Europe Solid Tumor Drug Sales (MT) Forecast by Countries (2017-2022)
Figure Europe Solid Tumor Drug Sales Market Share Forecast by Countries (2017-2022)
Table Europe Solid Tumor Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Solid Tumor Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Solid Tumor Drug Sales (MT) Forecast by Countries (2017-2022)
Figure Middle East Solid Tumor Drug Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Solid Tumor Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Solid Tumor Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Solid Tumor Drug Sales (MT) Forecast by Countries (2017-2022)
Figure Africa Solid Tumor Drug Sales Market Share Forecast by Countries (2017-2022)
Table Africa Solid Tumor Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Solid Tumor Drug Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Solid Tumor Drug Sales (MT) Forecast by Type (2017-2022)
Figure EMEA Solid Tumor Drug Sales Market Share Forecast by Type (2017-2022)
Table EMEA Solid Tumor Drug Sales (MT) Forecast by Application (2017-2022)
Figure EMEA Solid Tumor Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources